PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826FAB8D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,400
Award facts
- Contract value 100% obligated
- $14,399.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,399.66 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's contract performance demonstrates extensive capability in delivering both brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. As a child contract under the larger SPE2DX IDC, this delivery order exemplifies the company's role within the DLA's pharmaceutical supply chain operations, which strategically plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards to ensure robust medical supply capabilities across the defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2D826FAB8D?
SPE2D826FAB8D was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 3, 2025.
How much is contract SPE2D826FAB8D worth?
The government has obligated $14,400 on SPE2D826FAB8D.
Is contract SPE2D826FAB8D an order under another contract?
Yes. SPE2D826FAB8D is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAB8D competed?
The extent of competition for SPE2D826FAB8D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award